Timigutuzumab (Anti-ERBB2 / HER2 / CD340) | EGFR antibody | Read Reviews & Product Use Citations

Timigutuzumab (Anti-ERBB2 / HER2 / CD340) is a humanized immunoglobulin that targets the extracellular domain of the human epidermal growth factor receptor 2 (ErbB2, also known as HER2). Timigutuzumab can be used for cancer research. MW: 150 KD.

Purity & Quality Control

≥99

Choose Selective EGFR Inhibitors

Biological Activity

Description	Timigutuzumab (Anti-ERBB2 / HER2 / CD340) is a humanized immunoglobulin that targets the extracellular domain of the human epidermal growth factor receptor 2 (ErbB2, also known as HER2). Timigutuzumab can be used for cancer research. MW: 150 KD.

References
[1] De Santis R. MAbs. 2020;12(1):1725346.

References

[1] De Santis R. MAbs. 2020;12(1):1725346.

Product Details

CAS No.	1665274-14-5
Molecular Weight	150
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field